Filing Details

Accession Number:
0001140361-18-024283
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-16 19:10:56
Reporting Period:
2018-05-14
Accepted Time:
2018-05-16 19:10:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1444380 Nevro Corp NVRO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1417976 H Andrew Galligan C/O Nevro Corp.
1800 Bridgeway Parkway
Redwood City CA 94065
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-05-14 7,000 $18.00 35,192 No 4 M Direct
Common Stock Disposition 2018-05-14 7,000 $76.14 28,192 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-05-14 7,000 $0.00 7,000 $18.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
21,463 2024-11-04 No 4 M Direct
Footnotes
  1. Includes 18,125 restricted stock units.
  2. The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
  3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $75.85 to $76.64, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  4. 1/48th of the shares subject to the option vest on each monthly anniversary measured from November 5, 2014 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.